Newport Beach, CA, United States of America

Donald C Freeman, Jr

This inventor holds 1 USPTO granted patent. Top assignee: Hancock Jaffe Laboratories, Inc.. Active years: 1989.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Donald C Freeman, Jr. Retrieved from https://idiyas.com/inventor/donald-c-freeman-jr-uwr955yv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 1.0

ph-index = 1

Forward Citations = 80(Granted Patents)


Company Filing History:


Years Active: 1989

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Donald C Freeman, Jr.

Introduction

Donald C Freeman, Jr. is a notable inventor based in Newport Beach, CA. He has made significant contributions to the field of biomedical engineering, particularly in the area of xenogeneic tissue implants. His innovative work has the potential to enhance medical treatments and improve patient outcomes.

Latest Patents

Freeman holds a patent for the "Enhancement of xenogeneic tissue." This patent describes a method for preparing xenogeneic tissue implants by precrosslinking proteins in the tissue using glutaraldehyde. The process is followed by irradiating the crosslinked tissue with high-energy radiation, such as gamma radiation, to sterilize it, reduce immunogenicity, and improve the compliance and physical properties of the tissue. This advancement is crucial for the development of safer and more effective tissue implants.

Career Highlights

Freeman is associated with Hancock Jaffe Laboratories, Inc., where he applies his expertise in developing innovative medical solutions. His work at the company focuses on enhancing the quality and functionality of medical implants, which can significantly impact patient care.

Conclusion

Donald C Freeman, Jr. is a pioneering inventor whose work in xenogeneic tissue enhancement showcases his commitment to advancing medical technology. His contributions are vital for the future of biomedical engineering and patient treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…